Autophagy-related 4B cysteine peptidase (ATG4B) is highly expressed in CD34+ cells from CML patients, and knockdown of ATG4B sensitizes these cells to TKI treatment [64]. Here, ATG4B is linked to chronic myelogenous leukemia, BCR-ABL1 positive.